NCT06059547
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06059547
Title Neoadjuvant Immunotherapy in Combination With the Anti-GDF-15 Antibody Visugromab (CTL-002) for Treatment of Muscle Invasive Bladder Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors CatalYm GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
IRCCS Ospedale San Raffaele Hospital Vita-Salute San Raffaele University Milano 20132 Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milano 20133 Italy Details
Istituto Nazionale Tumori IRCCS - Fondazione Pascale Napoli 80131 Italy Details
Istituto Oncologico Veneto, IOV - IRCCS Padova 35128 Italy Details
ASL Salerno, Ospedale Andrea Tortora Pagani 84016 Italy Details
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Oncologia Medica Roma 00168 Italy Details
A.O.U. Città della Salute e della Scienza di Torino Torino 10126 Italy Details
Azienda Ospedaliera Ordine Mauriziano di Torino Ospedale Umberto I , SCDU Oncologia Torino 10128 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field